TABLE 2.
SHQ Total Score | NEI-VFQ Total Score | |||||
---|---|---|---|---|---|---|
mean | coefficient | P value | mean | coefficient | P value | |
Sarcoidosis | ||||||
Ocular | 3.88 | −0.13 | 0.52 | 69.08 | −13.64 | 0.00† |
Non-ocular | 4.01 | ref | 82.72 | ref | ||
Age | 48.28 | −0.01 | 0.16 | 48.28 | −0.09 | 0.66 |
Income | ||||||
<50K | 3.71 | −0.49 | 0.01† | 74.15 | −3.51 | 0.37 |
>50K | 4.19 | ref | 77.66 | ref | ||
Gender | ||||||
Female | 4.04 | 0.18 | 0.38 | 77.00 | 2.20 | 0.62 |
Male | 3.86 | ref | 74.80 | ref | ||
Race | ||||||
AA | 4.18 | 0.45 | 0.035* | 77.75 | 3.70 | 0.43 |
Others | 3.72 | ref | 74.05 | ref | ||
Disease duration | 10.21 | −0.0030 | 0.75 | 10.21 | −0.12 | 0.55 |
Treatment | ||||||
Treatment | 4.02 | 0.15 | 0.44 | 75.72 | −0.36 | 0.93 |
None | 3.88 | ref | 76.08 | ref |
p < 0.05,
p ≤ 0.01.
AA, African American; NEI, National Eye Institute; VFQ, Visual Functioning Questionnaire.